Cosmetic cross-reference Noindex: medium evidence

Ethyl Nicotinate

CAS 614-18-6

Ethyl Nicotinate (CAS 614-18-6) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Ethyl Nicotinate
CAS Number
614-18-6
UNII
NIJ3H353YH
InChIKey
XBLVHTDFJBKJLG-UHFFFAOYSA-N
ChEMBL ID
CHEMBL2251611
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Ethyl Nicotinate used for in pharmaceutical contexts?

Ethyl Nicotinate (CAS 614-18-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Ethyl Nicotinate?

No adverse-event association or SIDER side-effect rows are rendered for Ethyl Nicotinate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Ethyl Nicotinate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Ethyl Nicotinate with EU status "restricted".

What clinical phase is Ethyl Nicotinate in?

No phase 1-4 clinical development badge is rendered for Ethyl Nicotinate because the matched compound identifier rows do not contain a max-phase value.